In the BioHarmony Drug Report Database

"Preview" Icon

Metreleptin

Myalept, Myalepta (metreleptin) is a protein pharmaceutical. Metreleptin was first approved as Myalept on 2014-02-24. It is used to treat lipodystrophy in the USA. It has been approved in Europe to treat familial partial lipodystrophy.

 

Trade Name

 

Myalepta
 

Common Name

 

metreleptin
 

ChEMBL ID

 

CHEMBL2107857
 

Indication

 

familial partial lipodystrophy, lipodystrophy
 

Drug Class

 

Leptin derivatives

Image (chem structure or protein)

Metreleptin structure rendering